SP1/AKT/FOXO3 Signaling Is Involved in miR-362-3p-Mediated Inhibition of Cell-Cycle Pathway and EMT Progression in Renal Cell Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SP1/AKT/FOXO3 Signaling Is Involved in miR-362-3p-Mediated Inhibition of Cell-Cycle Pathway and EMT Progression in Renal Cell Carcinoma

Published:2020-05-05 Issue: Volume:8 Page:
ISSN:2296-634X
Container-title:Frontiers in Cell and Developmental Biology
language:
Short-container-title:Front. Cell Dev. Biol.

Author:

Zhu Hejia,Wang Song,Shen Haixiang,Zheng Xiangyi,Xu Xin

Funder

Natural Science Foundation of Zhejiang Province

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Cell Biology,Developmental Biology

Reference24 articles.

1. MicroRNA 362-3p reduces hERG-related current and inhibits breast cancer cells proliferation.;Assiri;Cancer Genomics Proteomics,2019

2. MicroRNAs: genomics, biogenesis, mechanism, and function.;Bartel;Cell,2004

3. Sp1 and the ‘hallmarks of cancer’.;Beishline;FEBS J.,2015

4. Epidemiology of renal cell carcinoma.;Capitanio;Eur. Urol.,2019

5. MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins.;Chen;Cancer Lett.,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSAT1 Promotes Metastasis via p-AKT/SP1/ITGA2 Axis in Estrogen Receptor-Negative Breast Cancer Cell;Biomolecules;2024-08-12

2. Three possible diagnostic biomarkers for gastric cancer: miR-362-3p, miR-362-5p and miR-363-5p;Biomarkers in Medicine;2024-06-17

3. MiR362-3p Alleviates Osteosarcoma by Regulating the IL6ST/JAK2/STAT3 Pathway in Vivo and in Vitro;Technology in Cancer Research & Treatment;2024-01

4. Identifying Stress-Exacerbated Thermal-Injury Induced MicroRNAs;The Journal of Pain;2023-12

5. FBXL6 depletion restrains clear cell renal cell carcinoma progression;Translational Oncology;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3